Article Details
Retrieved on: 2018-05-03 01:57:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Acadian Asset Management</b> LLC boosted its position in shares of Summit Therapeutics by 192.8% during the 4th quarter. <b>Acadian Asset Management</b> LLC now owns 144,083 shares of the company's stock worth $1,595,000 after acquiring an additional 94,876 shares in the last quarter. 28.98% ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here